scispace - formally typeset
Open AccessJournal ArticleDOI

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

TLDR
Authors/Task Force Members (François Macha, Colin Baigentb,∗∗,2, Alberico L. Catapanoc), ESC Committee for Practice Guidelines (CPG) (Stephan Windeckeraa), ESC National Cardiac Societies (Djamaleddine Nibouchean, Parounak H. Patelcl)
About
This article is published in Atherosclerosis.The article was published on 2019-09-02 and is currently open access. It has received 2972 citations till now. The article focuses on the topics: Lipid modification & Very low-density lipoprotein.

read more

Citations
More filters
Journal ArticleDOI

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry

TL;DR: The first usage experience of the Vietnam FH (VINAFH) Registry is reported, which contributed to the formation of the government agencies legislative acts that established the importance of FH as a socially and medically important disease requiring appropriate management strategies.
Journal ArticleDOI

Pharmacological management of cardiovascular risk in chronic inflammatory rheumatic diseases.

TL;DR: Current narrative review discusses pharmacological therapies available and emerging therapies aiming to help patients achieve recommended targets, depending on their individual risk, in patients with chronic inflammatory rheumatic diseases.
Journal ArticleDOI

Comentario del CEIPV a la actualización de las Guías Europeas de Prevención Vascular en la Práctica Clínica

TL;DR: In this update, greater stress is laid on the population approach, and especially on the promotion of physical activity and healthy diet through dietary, leisure and active transport policies in Spain, as is a recommendation against prescribing antiaggregants in primary prevention.
Journal ArticleDOI

Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers.

TL;DR: In this article , the authors considered the most common causes of nonalcoholic fatty liver disease (NAFLD) in the United States and worldwide, and proposed a treatment for NASH.
Journal ArticleDOI

Dyslipidemia Management in Pregnancy: Why Is It not Covered in the Guidelines?

TL;DR: The characteristics of lipid disorders and the possible management with dyslipidemia in pregnant women and the decisions on lipid-lowering therapy in pregnant patients should be individualized are reviewed.
References
More filters
Journal ArticleDOI

Atherosclerosis — An Inflammatory Disease

TL;DR: Atherosclerosis is an inflammatory disease as discussed by the authors, and it is a major cause of death in the United States, Europe, and much of Asia, despite changes in lifestyle and use of new pharmacologic approaches to lower plasma cholesterol concentrations.
Journal ArticleDOI

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia, +89 more
TL;DR: In this article, a randomized controlled trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly people was presented. But the authors did not discuss the effect of the combination therapy in patients living with systolic hypertension.
Journal Article

Atherosclerosis is an Inflammatory Disease

TL;DR: Despite changes in lifestyle and the use of new pharmacologic approaches to lower plasma cholesterol concentrations, cardiovascular disease continues to be the principal cause of death in the United States, Europe, and much of Asia.

Standards of Medical Care in Diabetes

TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Related Papers (5)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach, +120 more